4. Wood NS, Marlow N, Costeloe K, Gibson AT, Wilkinson AR. Neurologic and developmental disability after extremely preterm birth. EPICure Study Group. N Engl J Med 2000;343:378–84.
5. Vohr BR, Wright LL, Dusick AM, Mele L, Verter J, Steichen JJ, et al. Neurodevelopmental and functional outcomes of extremely low birth weight infants in the National Institute of Child Health and Human Development Neonatal Research Network, 1993-1994. Pediatrics 2000;105:1216–26.
6. Silveira RC, Procianoy RS. High plasma cytokine levels, white matter injury and neurodevelopment of high risk preterm infants: assessment at two years. Early Hum Dev 2011;87:433–7.
7. Schlapbach LJ, Ersch J, Adams M, Bernet V, Bucher HU, Latal B. Impact of chorioamnionitis and preeclampsia on neurodevelopmental outcome in preterm infants below 32 weeks gestational age. Acta Paediatr 2010;99:1504–9.
8. Moore T, Johnson S, Haider S, Hennessy E, Marlow N. Relationship between test scores using the second and third editions of the Bayley Scales in extremely preterm children. J Pediatr 2012;160:553–8.
10. Heo KH, Squires J, Lee SY, Lee JS. Korean ages and stages questionnaires/ a parent completed development screening tool. Seoul: Seoul Community Rehabilitation Center, 2006.
12. Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723–9.
13. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529–34.
15. Martin RJ, Fanaroff AA, Walsh MC. Fanaroff and Martin's neonatal-perinatal medicine. 10th ed. Philadelphia (PA): Elsevier Health Sciences, 2014.
16. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005;123:991–9.
17. Pascal A, Govaert P, Oostra A, Naulaers G, Ortibus E, Van den Broeck C. Neurodevelopmental outcome in very preterm and very-low-birthweight infants born over the past decade: a meta-analytic review. Dev Med Child Neurol 2018;60:342–55.
19. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359:262–73.
21. Anderson PJ, De Luca CR, Hutchinson E, Roberts G, Doyle LW; Victorian Infant Collaborative Group. Underestimation of developmental delay by the new Bayley-III Scale. Arch Pediatr Adolesc Med 2010;164:352–6.
22. Aylward GP. Developmental screening and assessment: what are we thinking? J Dev Behav Pediatr 2009;30:169–73.
23. Bayley N. Bayley scales of infant and toddler development. San Antonio (TX): The Psychological Corporation, 2006.
24. Doyle LW, Victorian Infant Collaborative Study Group. Evaluation of neonatal intensive care for extremely low birth weight infants in Victoria over two decades: I. Effectiveness. Pediatrics 2004;113(3 Pt 1): 505–9.
26. Kiechl-Kohlendorfer U, Ralser E, Pupp Peglow U, Reiter G, Trawöger R. Adverse neurodevelopmental outcome in preterm infants: risk factor profiles for different gestational ages. Acta Paediatr 2009;98:792–6.
27. Luttikhuizen dos Santos ES, de Kieviet JF, Königs M, van Elburg RM, Oosterlaan J. Predictive value of the Bayley scales of infant development on development of very preterm/very low birth weight children: a meta-analysis. Early Hum Dev 2013;89:487–96.
28. Bricker D, Squires J, Mounts L. Ages and stages questionnaire: a parent-completed, child monitoring system. Baltimore (MD): Paul H. Brookes, 1995;:156
32. Moon JS, Lee SY, Eun BL, Kim SW, Kim YK, Shin SM, et al. One-year evaluation of the national health screening program for infants and children in Korea. Korean J Pediatr 2010;53:307–13.
33. Eun BL, Chung HJ, Cho S, Kim JK, Shin SM, Lee JH, et al. The Appropriateness of the Items of Korean Ages and Stages Questionnaires (K-ASQ) Developmental Screening Test in Korean infants and children. J Korean Child Neurol Soc 2014;22:29–41.
34. Council on Children With DisabilitiesM; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children With Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics 2006;118:405–20.
35. Glascoe FP. Screening for developmental and behavioral problems. Ment Retard Dev Disabil Res Rev 2005;11:173–9.